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ABSTRACT
The autonomic nervous system (ANS) modulation of the heart is of clinical
importance because of its relevance to risk of life threatening arrhythmic events.
Decomposition of heart rate variability (HRV) has been used to quantify ANS control of
the heart. The traditional method for frequency analysis has involved the use of fast
Fourier transformation (FFT). However, heart rate data typically violate assumptions of
the FFT. Therefore, the assessment of HRV may benefit from other, potentially more
suitable, mathematical approaches. For example, the discrete wavelet transformation
(DWT) appears to have promise with respect to its ability to discriminate between
healthy and diseased populations. Therefore, the purpose of this thesis was to examine
the extent to which the FFT can discriminate between a control group and heart failure
patients (CHF) in comparison to DWT. Seven CHF (mean +/- standard deviation, age:
51.9 +/- 17.6 yrs) and eight age-matched controls (49.5 +/- 17.9 yrs) were evaluated.
HRV was evaluated during 5 minutes of supine spontaneous breathing (SB) and supine
paced breathing (PB) (0.2Hz). The ECG data were sampled at 200 Hz, converted to heart
rate tachograms, and subjected to frequency analysis via FFT and DWT. The FFT
approach did not reveal group differences in HRV, while the DWT revealed group
differences in LF/HF during SB (p<0.05) and PB (p=0.053). With respect to breathing
condition, only the FFT revealed that PB resulted in a decrease in low- to high-frequency
ratios (p<0.05), and an increase in standard deviation of normal R-R intervals. These
results support further consideration of both methods of analysis, as they each appear to
provide unique information about HRV.
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CHAPTER 1—INTRODUCTION
The last two decades have witnessed the recognition of a significant relationship
between autonomic nervous system function and cardiovascular mortality, including
sudden cardiac death. Experimental evidence for an association between propensity for
lethal arrhythmias and signs of either increased sympathetic or reduced vagal activity has
spurred efforts for the development of quantitative markers of autonomic activity (Task
Force, 1996).
Heart rate variability (HRV) represents one of the most promising such markers.
Autonomic markers such as HRV are receiving increasing attention for the identification
of patients at high risk. There is an increasing need for the development of sensitive tools
for risk factor stratification because of the danger of cardiac arrhythmias and sudden
cardiac death. It is important to identify in what populations these risks are most
prominent or pose a great amount of caution. The most crucial application of HRV
measurement is in its prognostic indication for sudden cardiac death. Typically, low HRV
has been associated with a higher risk for sudden cardiac death (Futterman & Lemberg,
1994). Therefore, developing the most appropriate tools for analysis of HRV is
important for risk stratification. Determining risk of cardiac events is an asset in
treatment and management of disease.
1.1 Heart Rate Variability Defined
HRV is a non-invasive measure of autonomic nervous system balance. This
method has been advanced as one capable of estimating relative parasympathetic and
sympathetic neural contributions to the modulation of the heart (Notarius et al., 1999).
HRV is measured in the time domain by familiar approaches to quantifying variability,
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such as in the case of standard deviation of R-R intervals or less frequently, of
instantaneous heart rate and R-R intervals. The R-R interval is the time duration between
consecutive R waves of an ECG. HRV has been quantified in the frequency domain by
way of fast Fourier transformation (FFT) of successive R-R intervals. Meaningful
analysis of HRV is dependent on the integrity of the basic cardiac signal input. This
cardiac input is usually in the form of the electrocardiogram, which has been widely
accepted as a statistical measure of HRV. Action potential propagation through the heart
generates electrical currents that can be detected at the surface of the body. The record of
these electrical events is called the electrocardiogram, abbreviated either ECG or EKG.
Collectively, the ECG is a composite recording of action potentials produced by all the
heart muscle fibers during each heartbeat (Tortora & Grabowski, 2000).
Depression of HRV has been observed in many clinical settings including
congestive heart failure, autonomic neuropathy, myocardial infarction, heart
transplantation, and other cardiac and noncardiac diseases. However, clinical implication
of HRV analysis has been clearly recognized in only two of these clinical conditions: (1)
as a predictor of risk of arrhythmic events or sudden cardiac death after acute MI and (2)
as a clinical marker of evolving diabetic neuropathy (Stys & Stys, 1998). In population
studies, decreased HRV has had predictive value for mortality among healthy adults. It is
a well-established risk factor for arrhythmic events and mortality among post-MI patients
but has only moderate sensitivity and specificity (Stein & Kleiger, 1999). The role of
HRV assessment has also been recognized and is still being applied in the evaluation and
management of heart failure.
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Although autonomic dysfunction can pose a threat to physiological health, there
are methods of intervention that have proven successful in decreasing negative effects of
autonomic imbalance. Common medications prescribed for these conditions include
calcium-channel blockers, beta-blockers, angiotensin-converting enzyme (ACE)
inhibitors, diuretics, and digitalis drugs. Medications for treatment of hypertension, heart
failure, diabetes and other conditions related to autonomic dysfunction help to control
symptoms and prevent exacerbation of these symptoms. Other types of medical
intervention include reconstructive surgery, heart transplants, and placement of
pacemakers.
Of particular relevance to the Kinesiologist is the use of physical activity as a
treatment strategy for the purpose of improving health outcomes and reducing
cardiovascular risk. Formal exercise and physical activity patterns have been associated
with improved HRV profiles in a variety of populations. More specifically, exercise
appears to increase vagal activity and attenuate sympathetic modulation of the heart
(Curtis & O’Keefe, 2002).
While all these treatments have been proven effective in many cases, it is crucial
that efforts are continued in order to evaluate treatment strategies. Measurement of HRV
can play an important role as a tool in prediction of disease and for risk stratification.
However, in the terms of treatment, it can also be used to determine the effectiveness of
the various strategies used to treat dysautonomia.
1.2 Justification for Research
Previous literature demonstrates that HRV assessment can be an effective clinical
tool. It can prove effective in assessing ANS function, as well as assessing effectiveness
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of the various approaches to treatment. However, there are pitfalls and complexities
involved in the measurement, analysis, and interpretation of HRV. The more common
tools used for HRV measurement tend to discriminate on merely a population basis. It is
our concern that analysis tools may be more beneficial if they separate on an individual
basis. Another concern is the ability of this technique to distinguish between healthy
individuals and those with autonomic dysfunction. The need to distinguish between these
populations would provide the means for enhanced as well as more specific treatment
strategies. The method in which HRV is analyzed may determine whether HRV can be
an effective discriminatory tool for separation between healthy and diseased populations.
1.3 Purpose of the Study
Therefore, the purpose of this study was to examine the potential of two different
types of HRV analyses in order to determine which is a more powerful tool for
discriminating between cardiac diseased and healthy populations. The only study to
specifically address this issue was performed using multiresolutional wavelet transform
technique. Ashkenazy et al. (1998) demonstrated that it is possible to distinguish with
complete certainty between healthy individuals and those with various cardiac nervous
system dysfunctions. It is apparent, by the lack of literature, that more data are needed to
confirm the important findings of Ashkenazy et al. Thus, it was our intention to discover
the ability of our laboratory to observe the same phenomenon.
1.4 Hypothesis
Based on the findings of Ashkenazy et al. (1998), we hypothesized that the use of
the wavelet transform in comparison to the FFT to analyze HRV data would be a more
powerful tool for discrimination between the cardiac diseased and the apparently healthy
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individuals in this study. Furthermore, there are some shortcomings of the Ashkenazy
model that we attempted to address by expanding the approach to include an index of
sympathovagal balance.
1.5 Limitations of the Study
Overall, the limitations of this particular study evolved around some aspect of the
subject population tested. Although there were no significant characteristic differences
between groups, the mean weight was higher in the CHF group. Also, the control group
may not have been extremely well matched to the CHF group. The individuals were
matched according to age. They were not matched based on gender, ethnicity, or
geographical location. All of which have been shown to be influential factors. Therefore,
it is possible that the fact that the majority of the participants (N=15) were females
(n=10) produced some bias. Finally, the medications that the CHF individuals were
taking may have impacted the results.
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CHAPTER 2—REVIEW OF LITERATURE
2.1 The Autonomic Nervous System
The autonomic nervous system (ANS) is the part of the nervous system that
functions to sustain life by controlling the heart, lungs, digestive system, blood pressure,
immune system, along with other human functions. It is considered the motor division of
the peripheral nervous system. The ANS has two major divisions (Figure 2.1): the
parasympathetic and sympathetic nervous system. These two systems originate from and
are activated by different sections of the spinal cord, brain stem, and hypothalamus.
Also, portions of the cerebral cortex and limbic cortex can transmit impulses to the lower
centers and influence autonomic control. The ANS also often operates by means of
visceral reflexes. Visceral reflexes are the sensory signals entering the autonomic
ganglia, cord, brain stem, or hypothalamus that can elicit appropriate reflex responses
directly back to visceral organs to control their activities (Guyton & Hall, 1996).
The effects of the sympathetic and parasympathetic systems are often
antagonistic, but both systems always function together (Wilmore & Costill, 1999). Most
body organs are innervated by both divisions of the ANS. The balance between the
sympathetic and parasympathetic activity or “tone” is regulated by the hypothalamus.
Typically, the hypothalamus turns up sympathetic tone at the same time it turns down
parasympathetic tone, and vice versa. The two divisions can affect body organs
differently because their neurons release different neurotransmitters. Also, effector
organs possess different adrenergic (sympathetic) and cholinergic (parasympathetic)
receptors, which determines how the ANS affects them.
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Figure 2.1 The Autonomic Nervous System
The sympathetic nervous system (SNS) releases the neurotransmitter responsible
for initiating the “fight-or-flight” response. During physical or emotional stress, the
sympathetic division of the ANS dominates the parasympathetic division. It prepares the
body for strenuous physical activity in the face of emergency or stressful situations. This
physiological response occurs with an increasing heart rate, more forceful heart
contractions, and an increase in blood pressure. All of these responses occur in an effort
to provide increased flow of oxygenated, nutrient-rich blood to skeletal muscles in
anticipation of strenuous physical activity. Also, the pupils dilate and the eyes adjust for
far vision, which enables one to make a quick visual assessment of the entire threatening
scene. Sweating is promoted, and unessential activities like digestive and urinary
activities are inhibited by the SNS. Some structures, such as sweat glands, the kidneys,
most blood vessels, and adrenal medulla, receive sympathetic innervation only. Along
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with physical exertion, a variety of emotions—such as, embarrassment, fear, or rage—
stimulate the SNS.
In contrast to the “fight-or-flight” activities of the sympathetic division, the
parasympathetic nervous system (PNS) enhances the “rest-and-digest” activities (Tortora
& Grabowski, 2000). The PNS is dominantly operated by the vagus, or tenth cranial
nerve. Vagal nerve control supports body functions that conserve and restore energy
during rest and recovery periods. In quiet intervals absent of stressful stimuli,
parasympathetic impulses to the digestive glands and smooth muscle of the
gastrointestinal tract predominate over sympathetic impulses. This predomination allows
energy-supplying food to be digested and absorbed. While the parasympathetic is
dominating the “at rest” body functions, it also reduces those functions that support
physical activity.
2.2 Autonomic Control of the Heart
The chronotropic (rate) and inotropic (contractility) behavior of the heart come
under the influence of the autonomic nervous system. Sympathetic mediated and
parasympathetic mediated activities, however, are mitigated through very different
mechanisms. The membrane processes of the cardiac sinoatrial (SA) node controls the
normal rhythm of the heart. The membrane processes are modulated by innervation from
both the sympathetic and parasympathetic divisions of the ANS. The nerve processes of
the PNS are composed of two neurons, each of which releases acetylcholine (ACH).
When ACH is released by postganglionic parasympathetic terminals at the sinoatrial
node, it slows the rate of SA node discharge and deploarization (Bernston et al., 1997).
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This decreased speed of SA node happens when the ACH binds to the muscarinic
cholenergic receptors to activate potassium channels.
Sympathetic nerve processes are also composed of two neurons. The first
releases ACH (like the PNS), but the second usually releases norepinephrine
(noradrenaline). The release of norepinephrine from the sympathetic terminals of the SA
node speeds the SA node rhythm. The speed is increased as a result of the β1 receptormediated second messenger intracellular signals. Chemical mediators released from the
autonomic nerve endings bind to receptors in the cell membranes of target tissues. The
mediators frequently change postsynaptic target tissue membrane permeability to ions.
ACH slows the heart by decreasing the resting membrane potential. Norepinephrine,
which is predominantly released by SNS neurons speeds the heart via stimulation of
cation influx. However, the initial transmitter substances can only cause temporary
changes in neurons. The ion channels are not suitable for causing prolonged postsynaptic
neuronal changes because these channels close within milliseconds after the transmitter
substance (norepinephrine or ACH) is no longer present (Guyton & Hall, 1996).
Many functions of the ANS require prolonged changes in neurons after the initial
transmitter substance is gone. In many instances, this prolonged action is achieved by
activating a “second messenger” chemical system inside the postsynaptic neuronal cell
itself. Then the second messenger causes the prolonged effect (Guyton & Hall, 1996).
One type of second messenger system is one that uses a group of proteins called Gproteins (Figure 2.2). The G-protein is attached to the portion of the receptor protein that
protrudes to the interior of the cell. The G-protein consists of three components: the
alpha (α) which is the activator portion of the G-protein, and beta (β) and gamma (γ),
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components that attach the protein to the inside of the cell adjacent to the receptor
protein.
Neurotransmitter:
Norepinephrine

Ca2+
B1
AC

G

cAMP

ATP
Inactive PK

Plasma
Membrane

Active PK

enzyme
ATP
ADP

Physiological
responses

enzyme -

Figure 2.2-Second Messenger System with G-protein
Along with the neurotransmitter actions, the chronotropic state of the heart can be
modulated by a variety of factors. However, direct autonomic innervation of the SA node
is the main influence to which the chronotropic activity of the heart is attributed. The
sympathetic system can indirectly regulate heart rate through the release of
adrenomedullary catecholamines. Other humoral factors that may influence HRV include
variations in the renin-angiotensin system (Akselrod et al., 1981).
2.3 Measurement of the Autonomic Nervous System
There are various methods employed in measuring ANS activity. Some
approaches involve blood pressure and heart rate measurements. Measurement of blood
pressure and heart rate responses to stressful stimuli in a laboratory environment is a
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widely used method for investigating autonomic control (Grassi et al., 1996). However,
there are limitations involved with using stressful stimuli because of the difficulty in
standardizing them. Also, laboratory stressor maneuvers require continuous monitoring
and are not always powerful enough to initiate measurable changes.
Measuring cardiac norepinephrine spillover has been used as an index of
sympathetic nerve firing rate. Although cardiac sympathetic activity may be clinically
important, some methods of measurement, such as assessing cardiac norepinephrine
overflow, are invasive and unsuitable for widespread application or repeated
measurement (Kingwell et al., 1994). Kingwell et al. show that in pure autonomic failure
and soon after transplantation, cardiac norepinephrine spillover was negligible, and HRV
was low. This proposes another disadvantage of this method of measurement. However,
the evidence that plasma norepinephrine concentration is significantly and independently
correlated with mortality in patients with congestive heart failure raises the possibility
that this simple measurement might provide a useful guide to clinical decision-making in
individual patients. Such predictive tests would be helpful in personal planning as well
as in selecting therapeutic strategies, including new drugs and heart replacement
procedures (Rector, Olivari, Levine, Francis, & Cohn, 1987).
While measurement of catecholamines may prove beneficial in providing
information in some clinical settings, there are other concerns with the use of this
technique. Recently, Forslund et al. (2002) assessed the prognostic impact of autonomic
activity reflected by catecholamines and HRV in patients with stable angina pectoris.
Forslund et al. found low HRV to be a predictor of cardiovascular death and that the
analyses of catecholamines carried no prognostic information. Furthermore, an increase
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in catecholamine levels does not automatically indicate autonomic dysfunction. Other
factors, such as reuptake or clearance of catecholamines could also be the cause of the
excess in these levels.
Measurement of heart rate and evaluation of its rhythmicity have been used for a
long time as a simple clinical indicator (Ashkenazy et al., 1998). Variation and
fluctuation of the heart rate in relation to mean heart rate have been shown to be a
function of cardiorespiratory physiology (Dreifus et al., 1993). It has been known for
several decades that enhanced vagal tone has a salutary effect on the electrophysiologic
properties of the ventricle to prevent the emergence of life-threatening ventricular
arrhythmias in certain situations. Therefore, Dreifus et al. concluded that HRV may offer
information about sympathetic and parasympathetic autonomic function and could serve
as a measure of risk stratification for serious cardiac arrhythmias and possible sudden
cardiac death. The most important application of HRV analysis is in its prognostic
indication for sudden cardiac death (Futterman & Lember, 1994).
2.4 Clinical Relevance of Autonomic Dysfunction
A balance between the two branches of the ANS is essential for good health. A
majority of illnesses and injuries are caused or result from an imbalance in the two
branches of the ANS. Any type of dysfunction or imbalance between the two branches of
the ANS is referred to as dysautonomia. Dysautonomia may also refer to failure of the
ANS. Autonomic imbalance has the potential to influence cardiac events. Cardiac
events such as variability in heart rate or blood pressure can be affected by autonomic
dysfunction. As a result of changes in HRV, other diseases or events may occur such as
heart failure and myocardial infarction. Thus, early subclinical detection of autonomic
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dysfunction by measurement of HRV is important for risk stratification and subsequent
management (Task Force, 1996).
Autonomic dysfunction is associated with and contributes to the progression of
chronic congestive heart failure (CHF). Autonomic dysfunction is an important feature
of congestive cardiac failure. Heart failure is a progressive disorder in which damage to
the heart causes weakening of the cardiovascular system. It can be clinically manifested
by fluid congestion or inadequate blood flow to tissues, which is referred to as
myocardial ischemia. Heart failure progresses by inappropriate responses of the body to
injury of the heart. It is a complex condition because it may be a result of one or many
different causes. For example, cases of untreated long-term hypertension can evolve into
development of cardiac failure. Heart failure is a disorder that has to be managed in
regard to not only the state of the heart, but the condition of circulation, lungs,
neuroendocrine system and other organs.
Eckberg, Drabinsky, and Braunwald (1971) were the first to show that there was
defective cardiac parasympathetic control in patients with heart failure. In CHF,
activation of several neurohumoral systems, such as the sympathetic nervous system,
renin-angiotensin system, and the argininevasopressin system occurs (Soejima et al.,
2000). High plasma levels, increased sympathetic nerve activity, resetting of baroreflex
control, and parasympathetic withdrawal have been reported in patients affected by this
syndrome (Lucreziotti et al., 2000). Soejima et al. concluded that the level of
catecholamines, mostly norepinephrine, increases and is correlated with the severity of
heart failure. Increased sympathetic activity in CHF has also been well documented by
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increased cardiac noradrenaline overflow and muscle sympathetic activity. Thus, CHF is
a known condition that may develop over time as a result of dysautonomia.
It has been reported that hypertension has some of the same findings in HRV as
those in heart failure. Langewitz, Ruddel, and Schachinger (1994) found reduced
parasympathetic function in hypertensive patients. Also, Langewitz et al. (1994) reported
hypertension to be characterized by a depressed circadian rhythmicity of LF. Other
investigators found hypertensive patients to have increased sympathetic nervous system
activity even at rest (Guzzetti et al., 1991). So, hypertension can provide important
lessons about the adverse effects of sympathetic predominance (Curtis & O’Keefe, 2002).
High blood pressure can be a sign of chronic imbalance of the autonomic nervous system.
Coronary artery disease (CAD) is a risk factor for myocardial infarction (MI).
Individuals with MI are at high risk for cardiac mortality and usually have decreased
HRV. CAD is a type of cardiovascular disease usually caused by atherosclerosis, a
progressive and degenerative arterial condition leading to occlusion of affected blood
vessels. This pathology can lead to a reduction in blood flow. Reduced blood flow can
eventually affect the balance of the autonomic nervous system. The association of
autonomic imbalance with incident cardiovascular disease and all-cause mortality in the
general population has been attributed to subclinical coronary artery disease (Gerritsen et
al., 2001). Decreased HRV is associated with an adverse prognosis in patients with
coronary artery disease (Hayano et al., 2001).While the depression of HRV has been
observed in many clinical settings, the clinical implication of HRV analysis has been
clearly recognized in only two of these clinical contexts: (1) as a predictor of risk of
arrhythmic events or sudden cardiac death after acute MI and (2) as a clinical marker of
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evolving diabetic neuropathy (Stys & Stys, 1998). The role of HRV assessment has also
been recognized and is still being applied in the evaluation and management of heart
failure.
The importance of HRV for the stratification of patients who are at high risk after
acute myocardial infarction (AMI) has been well documented (Malik, Farrell, & Camm,
1990). The prognostic value of HRV with respect to survival from and outcome of MI
has attracted increasing interest (Moser et al., 1994). Because HRV mirrors autonomic
equilibrium, it is not surprising that recent studies revealed prognostic possibilities for
HRV measurements following myocardial infarction (Moser et al., 1994).
Dysfunction of the autonomic nervous system is associated with increased risk of
mortality in patients with diabetes, survivors of myocardial infarction, and unselected
middle-aged elderly subjects (Gerritsen et al., 2001). Gerritsen et al. has explained this
by the fact that autonomic imbalance predisposes individuals to cardiac arrhythmias.
Subjects with diabetes are known to be at high risk of developing autonomic dysfunction,
and autonomic dysfunction is already present in patients with newly diagnosed diabetes
(Lehtinen, Uusitupa, Siitonen, & Pyorala, 1989). As a complication of diabetes mellitus,
autonomic neuropathy is characterized by early and widespread neuronal degeneration of
both sympathetic and parasympathetic tracts of the nervous system (Task Force, 1996).
The severity of autonomic neuropathy is marked by the fact that it affects both
components of the ANS.
2.5 Heart Rate Variability
HRV is a time series that bears information on instantaneous heart rates or current
R-R intervals. Usually, increased HRV reflects increased autonomic modulation of the
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heart, and the converse is also true (Stein & Kleiger, 1999). Measures of HRV are
increasingly being employed in applications ranging from basic investigations of central
regulation of autonomic state, to studies of fundamental links between psychological
processes and physiological functions, to evaluations of cognitive development and
clinical risk (Berntson et al., 1997).
2.6 Heart Rate Variability Quantified in Frequency
Although, the influence of ANS on HRV was recognized early in this century,
only recently have several studies made it clear that the parasympathetic and sympathetic
activities influence HRV at different parts of the frequency spectrum (Moser et al., 1994).
Mathematical analysis of HRV shows that heart rate is influenced by different frequency
components because these components arise as a result of different signaling mechanisms
of the heart.
The two branches of the ANS, the PNS and SNS, both play a role in modulating
normal activity of the heart. A normal heart rhythm is controlled by membrane processes
of the cardiac sinoatrial (SA) node. However, these processes may differ based on which
branch of the ANS is playing the dominant role in activation. Heart rate fluctuations may
occur as a result of the different signaling mechanisms of the PNS and SNS.
Studies have summarized that cardiac response to vagal (PNS) activity is rapid,
while the response to sympathetic activity is slower characterized with a time delay.
Spear, Kronhaus, Moore, and Kline (1979) examined heart period responses to
sympathetic and parasympathetic activity. Their study demonstrated that a vagal burst
had its maximum effect at about 0.5seconds. This response returned to baseline within 1
second and then a slower rebound in direction of decreasing the R-R intervals. The
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sympathetic burst or stimulus had no effect for approximately 1 second and the return to
baseline occurred within 20 seconds. The maximum decrease in R-R intervals was seen
at approximately 4 seconds after the sympathetic burst was initiated. This feature may
explain why heart rates remain elevated several seconds after an excitatory stimulus is
introduced.
Berger, Saul, and Cohen (1989) and Penaz (1962) found similar impulse response
results using frequency-domain techniques. Here, the vagal filter had a corner frequency
of 0.15 Hz. Berger et al. (1989) also found that the corner frequency and response
characteristics varied slightly as a function of the mean vagal stimulation frequency. The
direct current intercept was larger at lower stimulation frequencies and the corner
frequency was lower than at higher frequencies. Berger (1987) also examined response
of sinus node to modulation of sympathetic nervous system activity. Similar to what was
reported by Spear et al. (1979), Berger found the sympathetic response to have a corner
frequency of 0.015 Hz. This revealed a time delay of about 1.7 seconds. The studies by
Berger (1987) and Spear et al. (1979) found similar results and summarized that vagal
responses are faster with little delay, whereas sympathetic responses are slower with a 12 seconds time delay.
The differences in the delay of cardiac response to sympathetic and
parasympathetic activation appear to be related to the receptor processes and postsynaptic
responses (Berntson et al., 1997). Hill-Smith and Purves (1978) determined that the
response characteristics were not due to differences in diffusion at muscarinic (vagal) or
adrenergic (sympathetic) receptors. This study suggested that the delay in cardiac
responses to these neurotransmitters probably arose from processes subsequent to the
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binding of the agonist to the receptor (Berntson et al., 1997). In addition, Hille (1992)
demonstrated that the linkage between muscarinic receptor activation and ionic current
changes is mediated by signaling molecules located within the cell membrane. The
parasympathetic neurotransmitter, ACH, is lipid-soluble and able to pass through cell
membrane without use of a second-messenger. This may explain why vagal stimulation
occurs much quicker and with little time delay than sympathetic stimulation.
Adrenergic (sympathetic) stimulation is initiated in the membrane and requires a
second-messenger activation of a protein kinase in the cytosol. This is necessary because
the neurotransmitter, NE, is a water-soluble molecule and unable to pass through the cell
membrane. The activation of the second-messenger eventually sends a signal back to the
membrane to change the ionic currents (Hille, 1992). This activity takes longer than that
of vagal activity because of the delay involved in the use of a second-messenger activator
rather than direct activation. This feature, as well as the rate of termination of receptor
action appear to be responsible for differences in time constants of sympathetic and vagal
responses (Levy, Yang, & Wallick, 1993).
Thus, HRV components tend to aggregate within several frequency bands
(Berntson et al., 1997). Respiratory frequency band (RSA) is the most conspicuous of
the bands. It is considered to range from about 0.15 Hz to 0.4 Hz in humans but may
extend below 0.15 Hz and up to 1 Hz or more in infants and adults during exercise
(Berntson et al., 1997). This frequency band range is referred to as the high-frequency
(HF) band (Task Force, 1996). RSA is generally believed to provide an index of vagal
activity, which is characterized by the HF band.
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R-R interval oscillations also occur at low frequencies (about 0.05-0.15 Hz). This
range is termed the mid-frequency range by some, but is more commonly known as the
low-frequency (LF) range. The LF heart rate rhythms have been suggested to reflect
mainly sympathetic outflow (Malliani, Pagani, Lombardi, & Cerutti, 1991; Malliani,
Pagani, & Lombardi, 1994) but have also been thought to reflect both sympathetic and
vagal activity (Akselrod et al., 1985; Pomeranz et al., 1985). Studies have shown the
parasympathetic nervous system to be able to modulate heart rate effectively at all
frequencies between 0 and 0.5 Hz. These frequencies are higher than that of the
sympathetic nervous system. Sympathetic modulation of heart rate occurred with
significant gain only at frequencies below 0.1 Hz (Berntson et al., 1997).
Bootsma et al. (1994) summarized LF and HF by reporting LF fluctuations to be
mediated by an unknown mixture of sympathetic and vagal influnces. Whereas, HF
fluctuations are believed to be solely vagally mediated. Furthermore, Bootsma et al.
along with other investigators (Malliani et al., 1994; Montano et al., 1994) have proposed
that power in the LF and HF reflects the relative balance between sympathetic and vagal
control. This is referred to as autonomic or “sympathovagal” balance and can be indexed
by the LF/HF ratio (Berntson et al., 1997).
2.7 Heart Rate Variability as a Method of Autonomic Measurement
Studies of the functional effects of phasic modulation of sympathetic and vagal
activities are especially pertinent to the patterns of heart rate variability (de Boer,
Karemaker, & Strackee, 1985; Somsen, Molenaar, van der Malen, & Jennings, 1991).
The previous paragraphs provide insight about the different signaling mechanisms of the
heart and how those ideas were developed. This information provides theoretical basis
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for HRV being employed as a measure of ANS activity. The developed theories explain
why the mechanisms are described in terms of frequency. Furthermore, it is clear why
investigators refer to sympathetic activity in terms of LF and parasympathetic as HF. To
develop theories to explain the control of the autonomic nervous system, many different
studies were performed. Because neither vagal nor sympathetic nerve traffic to the
human heart has been measured directly, conclusions regarding the heart rate fluctuations
are based on indirect evidence. The following studies have shown HRV to be an
effective tool in clinical assessment of ANS control of the heart.
HRV analysis has been employed in several different settings as a means of
measuring the autonomic nervous system. For instance, HRV analysis is commonly used
to assess the effect of exercise on the autonomic nervous system control of the heart.
Some studies have shown that exercise training may confer anticipatory protection from
sudden death by enhancing cardiovascular autonomic function (Hull et al., 1994). The
data found in this study supports the concept that good aerobic fitness may exert
cardioprotective effects by enhancing the cardiac vagal function during exercise.
Another study determined that HRV appears to be a potentially good indicator of
cumulated training load in middle-distance runners, which could help to plan training
programs (Pichot et al., 2000). This study confirmed that heavy training shifted the
cardiac autonomic balance toward a predominance of the sympathetic over the
parasympathetic drive. When recorded at night, HRV appeared to be a better tool than
resting heart rate to evaluate cumulated physical fatigue. This may be because of the
magnification of the induced changes in the ANS activity. These results may be of
interest for optimizing training profiles (Pichot et al., 2000).
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Perini, Fisher, Veicsteinas, and Pendergrast (2002) examined the effects of an
intense aerobic training program on cardiovascular responses at rest and during exercise
in older men and women. They also looked at HRV as an expression of autonomic
modulation and evaluated subjects over the age of 70 years. Perini et al. (2002)
demonstrated that aerobic training increased exercise capacity and decreased blood
pressure in the subjects. However, they saw no changes in autonomic regulation of the
heart. This particular study suggests that the adaptations to aerobic exercise used in this
study were peripheral in nature.
While Perini, Fisher, Veicsteinas, and Pendergrast (2002) found no adjustments in
ANS modulation, other studies conclude that physical activity may have an overall
positive effect on HRV. Myslivecek, Brown, and Wolfe (2002) examined the effects of
physical conditioning on cardiac autonomic function in healthy middle-aged women.
The exercise protocol was a 12 week walking program. After training, participants
displayed increased vagal modulation and during exercise vagal modulation was higher
with lower sympathetic modulation. All the participants improved according to the pretraining values.
HRV has been employed as a measure of autonomic activity in numerous studies
examining the effect of posture or tilt on the ANS. Cooke et al. (1999) examined the
interactions between autonomic neural oscillations during passive upright tilt. Using fastfourier transform spectral analysis they found integrated areas of muscle sympathetic
bursts and LF powers increased. The increases occurred directly and significantly with
the tilt angle. It was concluded that tilt produced sympathetic stimulation increases to a
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level that overwhelms the respiratory gate, and vagal stimulation decreases it to a level
below that necessary for maximal respiratory gating to occur.
Montano et al. (1994) also investigated the capability of HRV analysis to quantify
graded changes in sympathovagal balance induced by passive tilt. The results of this
study indicated that use of HRV analysis to assess progression of a sympathetic
excitation, of a vagal withdrawal, and consequently, of a shift in sympathovagal balance
were indeed efficient. It was confirmed in this study that analysis of HRV can
noninvasively quantify changes in sympathovagal balance accompanying graded passive
tilt. Bloomfield et al. (1997) examined change in autonomic balance as a result of
passive tilt in comparison to actively standing up. Although the initial 30 seconds of
standing up showed different changes in R-R intervals, the average changes in R-R
interval during the first five minutes of standing are similar to the average changes in R-R
interval during the first five minutes of passive tilt. Similar findings were reported in a
study by Bahjaoui-Bouhaddi, Henriet, Cappelle, Dumoulin, & Regnard (1998).
Patwardhan, Evans, Bruce, Eckberg, and Knapp (1995) performed a study in
which the effect of breathing on vagal modulation was investigated. They specifically
examined metronomic breathing to determine whether it complicates the interpretation of
heart rate spectra by altering vagal modulation. They compared the metronomic
breathing to spontaneous breathing patterns. Their findings showed heart rate power in
the respiratory frequency (where vagal modulation occurs) region. The results suggested
that vagal modulation of heart rate is not altered and vagal tone is not enhanced during
metronomic breathing.
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In another study, Bloomfield et al. (2001) questioned the report made by several
investigators that the HF band cannot be interpreted unless the breathing rate is
controlled. They measured HF power during spontaneous breathing and compared it to
HF power during metronome-guided breathing. They found no significant differences
between HF power measured during spontaneous and metronome breathing in the group
as a whole and when patients and healthy subjects were measured separately. The data
obtained indicate that HF power during spontaneous and metronome breathing differs at
most by very small amounts. In addition, they found HF power to be relatively constant
across the range of typical breathing rates. Bloomfield et al. concluded that there is no
need to control breathing rate to interpret HF power when RR variability, specifically HF
power, is used to identify high-risk cardiac patients.
Thus, HRV analysis has also been shown to be useful in determining whether
breathing patterns affect ANS modulation. Various studies (Bloomfield et al., 2001;
Bahjaoui-Bouhaddi, Henriet, Cappelle, Dumoulin, & Regnard,1998; Pichot et al., 2000;
de Boer, Karemaker, & Strackee, 1985; Somsen, Molenaar, van der Malen, & Jennings,
1991) were successful in discovering useful information about ANS control that can be
applied in a series of human and animal studies. HRV assessment has been explored as a
measure of autonomic activity in relation to effects of exercise or physical activity on the
ANS. Also, several studies using tilt or postural changes, as well as breathing patterns
have reported the use of HRV analyses as the measure of ANS activity.
In summary, many studies have shown that whenever the signal produced by
HRV was adequate and the sympathovagal balance was shifted toward a sympathetic
predominance with tilt, moderate hypotension (Rimoldi et al., 1990) mild physical
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exercise, mental stress (Pagani et al., 1991) or coronary artery occlusion (Rimoldi et al.,
1990) the LF or LF/HF component was augmented (Montano et al., 1994). This suggests
that various conditions do affect the modulation of the heart by the autonomic nervous
system and have validated the use of HRV as a measurement of autonomic activity.
Clearly, HRV represents one of the most promising quantitative markers of
autonomic activity. The easy derivation of this measure has popularized its use. As
many commercial devices now provide an automated measurement of HRV,
professionals have been provided with a seemingly simple tool for both research and
clinical studies (Task Force, 1996). Patterns of HRV hold considerable promise for
clarifying issues in physiology (Berntson et al., 1997).
2.8 Types of Heart Rate Variability Analysis
There are two basic approaches to quantifying HRV (a) the use of global
descriptive statistics to characterize the distribution of heart periods (e.g., range, standard
deviation, and variance) and (b) modeling of periodic patterns to extract specific
frequency components of variance that relate to functional processes or physiological
mechanisms (Berntson, et al., 1997). The variations in heart rate may be evaluated by a
number of methods. There are two approaches to the measurement of HRV: analysis in
the time or in the frequency domain. Perhaps the simplest to perform are the time
domain measures, in which either the heart rate at any point in time or the intervals
between successive normal complexes are determined (Task Force, 1996).
Time and frequency domain analysis are both types of spectral methods used to
analyze HRV. Simple time domain measures can then be calculated such as, the mean
NN (R-R) interval, the mean heart rate, the difference between the longest and the
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shortest NN interval, and so forth. There are two classes of time domain variables, one
based on interbeat intervals and the other based on comparisons of the lengths of adjacent
cycles (Stein, Bosner, Kleiger, & Conger, 1994). Those based on interbeat intervals
include the standard deviation of all normal R-R intervals (SDNN), and the standard
deviation of the mean of 5-minute intervals, averaged over a 24-hour period (SDANN).
The HRV triangular index is also an estimate of overall HRV.
The second class of time domain variables based on comparisons of length
adjacent cycles includes the proportion of adjacent cycles that are >50 milliseconds apart
measured in percent (pNN50), and the root mean square successive differences (rMSSD), which is the square root of the averaged sum of squared differences in length
between all adjacent NN cycles (1994). Other time domain measurements that can be
used are variations in instantaneous heart rate secondary to respiration, tilt, Valsalva
maneuver, or phenylephrine infusion (Task Force, 1996).
Various spectral methods for the analysis of the tachogram have been applied
since the late 1960s (Task Force, 1996). Power spectral density (PSD) analysis provides
the basic information of how power (variance) distributes as a function of frequency.
Analysis in the frequency domain is mathematically more complex, but has been used by
a number of investigators (Stein, Bosner, Kleiger, & Conger, 1994). Stein et al. (1994)
concluded that frequency domain analysis yields information about the amount of the
overall variance in heart rate resulting from periodic oscillations of heart rate at various
frequencies. Investigation of the underlying rhythms is what is addressed using the
frequency domain analysis.
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2.9 Fast Fourier Transform
Fast Fourier transform (FFT) is one of the most common approaches to spectral
analysis of HRV. The majority of studies on cardiovascular signals have been performed
using a FFT (Lotric, Stefanovska, Stajer, & Rovan, 2000). FFT is a type of spectral
analysis that produces a decomposition of total variation of a data series into frequency
components. The FFT can produce frequency- and time-domain indices, but is
considered a frequency-domain method of HRV analysis. The FFT approach could be
considered a descriptive method and captures the data in either the time-or frequencydomain separately—not simultaneously. Although several types of analyses are
employed in HRV studies, the FFT is the form of spectral analysis examined in this
particular study.
2.10 Limitations of Fast Fourier Transform
FFT assumes that the time series contains only deterministic components and that
the data are stationary signals (Berntson et al., 1997). FFT-based techniques include all
data as oppose to the Autoregressive (AR) modeling, another form of spectral analysis,
which excludes “noise.” FFT, being a form of frequency-domain analysis, suffers from
several drawbacks. For example, it fails to provide time localization of signal
singularities characterized by high-frequency components (Gramatikov & Georgiev,
1995). Because of the low-amplitude windows produced by FFT, the most interesting
part of the QRS segment of the ECG is often masked out. This results in the possibility
of overlooking late potentials in the ECG. Late potentials are regarded as a manifestation
of delayed electrical conduction or reentry mechanism in the heart. Their diagnostic
prevalence has been discussed extensively (Berbari & Lazzara, 1992; Breithardt et al.,
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1982; Zimmerman, Adamec, Simonin, & Richez, 1985) and inability to detect them may
result in misdiagnoses.
Another problem posed by the FFT, is the difficulty to detect a given frequency.
This is complex because in order to detect a frequency, the signal must be observed for at
least one period of a particular frequency. Then, it is impossible to say exactly at which
time the signal had the particular frequency (Lotric et al., 2000). Another limitation of
the FFT is the resolution and its inadequacy in producing peaks at low frequencies. A
peak falling between frequencies that cannot be picked up by the FFT is undetected.
Moreover, this peak may contribute to all frequencies in the spectrum. FFT also assumes
that ECG signals are stationary in nature. This however, is not always the case.
2.11 Discrete-Wavelet Transform
The other form of HRV analysis in question in this particular study is the discrete
wavelet transform (DWT). The recently introduced wavelet transform is a member of the
class of time-frequency representations, which include the Gabor short-time Fourier
transform and Wigner-Ville distribution. In essence, a wavelet decomposition of a signal
amounts to its description in terms of shifted and dilated versions of some basis wavelet.
The shift operation allows signals to be localized in time, while the dilation operation
enables the scale of the original signal to be determined. Hence, a signal can be localized
in both time and scale (which can be considered as similar to frequency) dimensions thus
leading to the term “time-scale” representation (Crowe, Gibson, Woolfson, & Somekh,
1992). Wavelets were introduced by Grossman and Morlet in 1984. The method is
based on the multiresolution signal decomposition (Bartnik, Blinowska, & Durka, 1992).
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The wavelet techniques are of significance because of their ability to display the spectral
content of a signal as time elapses (Crowe et al., 1992).
The value of the wavelet transform as a signal analysis tool has been
demonstrated by its successful use in studying turbulence and processing of speech and
music. It has also been used for geophysics investigations and fractal analysis. Bartnik,
Blinowska, and Durka (1992) introduced wavelet formalism for the first time to brain
signal analysis. Akin (2002) compared wavelet transform to FFT methods in the analysis
of EEG signals and found WT to be a better method for detecting brain diseases.
2.12 Advantages of Wavelet Transform
DWT is a mathematical recipe that can be compared to FFT in respect to
orthogonality and invertiblity (Ashkenazy et al., 1998). However, unlike the FFT, the
logarithmic frequency resolution of the wavelet analysis makes it possible for this method
to capture simultaneously very different rhythms within a single signal (Lotric et al.,
2000).
Also, wavelet estimation is calculated directly from data, and no modeling is
involved as in the case of linear modeling. Wavelet frequency resolution of the wavelet
transform enabled the detection of peaks in very low frequency intervals instead of
masking out important parts of ECG data (Lotric et al., 2000). The wavelets are unit
vectors that correspond to sine and cosine basis functions of the FFT. They decompose
data sets more intrinsically, in turn, rendering functions with inaccuracies into more
reliable data than that of FFT (Ashkenazy et al., 1998).
Wavelet transform has better time resolution at higher scales than that of FFT.
This is directly related to the sampling patterns of the discrete transforms in phase-space.
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Therefore, the wavelet transform has the ability to localize singularities more accurately
in the time domain. Also, there is near perfect reconstruction from the transform
coefficients without the requirement for oversampling (Crowe et al., 1992). Ashkenazy
et al. (1998) established that large classes of biological data such as ECG series and R-R
intervals may analyzed by DWT.
2.13 Summary
Measures of HRV may offer powerful tools for clarification of relationships
between psychological and physiological processes. However, there are caveats and
pitfalls in the measurement, analysis, and interpretation of HRV (Berntson et al., 1997).
The significance of and meaning of the many different measures of HRV are more
complex than generally appreciated, and there is potential for incorrect conclusions and
for excessive or unfounded extrapolations (Task Force, 1996). There are other
limitations associated with the model of HRV most commonly used in clinical settings up
to date (FFT). With this being the case, it is possible that assessment of HRV would
benefit from other approaches such as wavelet transformation. Therefore, the purpose of
this study is to examine the extent to which the traditional approach to spectral analysis
of HRV can discriminate between healthy and diseased populations in comparison to
wavelet analysis.
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CHAPTER 3—METHODS
3.1 Participants
Seven (1 male, 6 females) class II and III CHF patients and eight (4 males, 4
females) volunteer control subjects were recruited to participate in this study. The CHF
patients were classified according to the New York Heart Association Heart Failure
Classifications (Table 3.1). The groups were matched according to age (mean +/standard deviation; CHF: 51.9 +/- 17.6 yrs; Control: 49.5 +/- 17.9 yrs). Individuals
recovering from recent hospitalization, with unstable myocardial ischemia and/or angina,
uncontrolled diabetes mellitus and/or hypertension were excluded from this study. Those
with lung disease, anemia, or renal failure were also prohibited from participation in this
study. All patients were still taking their physician prescribed medications during the
data collection for this study. The medications included beta-blockers, calcium-channel
blockers, diuretics, anti-coagulants, lipid-lowering agents, anti-anginal agents, ACE
inhibitors, and digitalis drugs. Additional medications taken by some of the participants
included: anti-anxiety agents, and hormone replacement therapy.

Table 3.1-New York Heart Association: Heart Failure Classifications
Classification

Symptoms

Class I

None

Class II

Mild symptoms and slight limitation during normal physical
activity. Comfortable at rest.
Marked limitation in activity due to symptoms, even during
limited activity. Comfortable only at rest.
Severe limitations of activity and symptoms at rest.

Class III
Class IV
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3.2 Medical History and Consent Forms
Every participant gave a self-report of his/her medical history (medications,
hospitalization, surgeries, falls etc.) and tobacco history (smoker, non-smoker, tobacco
type, number of years as a smoker, etc.) Each participant received a comprehensive
explanation of the study. The explanation included instructions, benefits, and inherent
risks, as well as expected commitments. Following the explanation, all participants
signed an informed consent approved by the Institutional Review Board of Louisiana
State University.
3.3 Experimental Procedure
All measurements were performed on each subject in a quiet examination room.
Each participant rested on an examination table in supine position and allowed fifteen
minutes to adapt to the testing environment before measurements were obtained. For the
purpose of this study, the following stages of measurement were focused on (1) supine
position with spontaneous breathing (SB) for five minutes (2) supine position with paced
breathing (PB) for five minutes. SB is the term used to refer to the normal breathing
pattern, while PB consists of one breath every 5 seconds. Each breath consisted of an
inhalation and exhalation each lasting 2.5 seconds in duration. A blood pressure cuff was
placed on the left arm of the participant and blood pressures were taken automatically
during testing. During each stage, heart rate and blood pressure measurements were
obtained. The event marker on the Biopac System was used to mark the beginning and
end of each stage in the protocol.
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In addition, each participant performed a six-minute walk test. The total distance
each participant walked was recorded in meters. Their HR, BP, and RPE were recorded
as well.
3.4 Data Reduction and Analysis
The electrocardiogram signal was captured by the Biopac System and digitized
using Acknowledge computer software. Three-lead electrocardiogram signals were
transformed into tachograms by the Acknowledge software, and resampled at 4 Hz. The
tachograms were then analyzed for the standard deviation of all normal R-R intervals
(SDNN). The tachogram was then subjected to a FFT and the resultant power spectrum
was examined for LF, HF, and LF/HF ratios. All the data were subjected to analysis
using the Matlab version 6.3 software. HF power is a pure parasympathetic signal
modulated by respiration (Pomeranz, et al., 1985). LF is modulated by baroreflex
activity and provides information about both sympathetic and parasympathetic
modulation of R-R intervals. The ratio of LF power to HF power will be calculated as an
index of autonomic balance. The data were also submitted to the Daubechies-4tap
discrete wavelet transformation (DWT). This transformation computes coefficients (or
powers) that are occurring at different levels of frequency. In the case of 256 intervals
the Daubechies 4-tap computes 7 different levels (1-7) corresponding to events cycling
every 2, 4, 8,16, 32, 64, and 128 intervals beats, respectively. The frequency that the
level relates to is also a function of the length of the average R-R interval. Typically
however, events cycling every 16-32 intervals are relatively low in frequency of
occurrence, whereas events cycling every 4 or 8 intervals are typically representing HF
oscillations. After computing the coefficients at all 7 levels, the MATLab script was
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written so as to pick out the levels describing LF oscillations, sum the coefficients, and
then divide by the sum of the coefficients of the levels describing HF oscillations. This
ratio was used as wavelet derived low-to-high frequency ratio of sympathovagal balance.
3.5 Statistical Analysis
All statistical analyses were performed using SPSS statistical software. The data
were expressed in mean and standard deviation. A mixed-model analysis of variance
(ANOVA) was employed to examine the main effects of group (CHF vs. control) and
breathing condition (SB and PB), as well as, group by breathing condition interactions.
T-tests were used to examine possible differences between the SB and PB conditions
within both groups. The t-tests were also used to examine the differences in participant
characteristics (height, weight, BMI, and age) between the two groups. For the statistical
analyses, alpha was set a-priori at 0.05. The R-R intervals were examined along with the
SDNN, HF, LF, pNN50, RMSSD, and LF/HF ratio of the R-R intervals. The LF/HF
ratio data were collected from the FFT and wavelet analysis. These data were plotted in
order to visualize differences between the FFT and the wavelet data. Finally, we used
Pearson correlation coefficient to report the wavelet derived LF/HF ratios during SB and
PB for any correlation with the six-minute walk distance and BMI of each participant.
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CHAPTER 4—RESULTS
Fifteen individuals participated in this study. Seven of them had been diagnosed
with the condition of heart failure and the others were volunteers without any type of
cardiovascular disease and served as the control group. There were no differences in
CHF and Control group participant characteristics as described below in Table 4.1.
Table 4.1- Participant Characteristics
Characteristics

CHF

Control

n

7

8

Age (yrs)*

51.9 +/- 17.6

49.5 +/- 17.9

Height (cm)*

164.5 +/- 5.5

172.9 +/- 11.4

Weight (kg)*

98.3 +/- 25.6

78.7 +/- 12.9

Gender

1 male, 6 females

4 males, 4 females

*Values are mean +/- standard deviation
A number of acronyms will be used throughout the results chapter. For reference
purposes, the following table (Table 4.2) presents these acronyms and their
corresponding definitions.
Table 4.2-Acronyms
Variable
SBP

Definition
Systolic Blood Pressure

DBP

Diastolic Blood Pressure

HR

Heart Rate

SB

Spontaneous Breathing

PB

Paced Breathing
Table 4.2 continued on next page
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LF

Low Frequency

HF

High Frequency

SDNN

Standard Deviation of all NN intervals

LF/HF

pNN50

Measure of sympathovagal balance, reflection of sympathetic
modulations
The square root of mean of sum of squares of differences between
adjacent NN intervals
Number of pairs of adjacent NN intervals differing by more than 50 ms in
the entire ECG recording
NN50 count divided by total number of all NN intervals

nu

Normalized units

BMI

Body Mass Index

RMSSD
NN50

Table 4.3-Blood Pressure and Heart Rate Responses
CHF
Breathing
Condition
SBP

SB
136 +/- 16.6

DBP
HR

Control
PB

SB

PB

133 +/- 16.9 †

128.2 +/- 15.7

125.7 +/- 15.7 †

82 +/- 11.9

81.8 +/- 13.6 †

71.2 +/- 7.96

72.5 +/- 4.2 †

78.7 +/- 11.9

77.6 +/- 11.3 ††

61.7 +/- 5.0

62.5 +/- 8.5 ††

Acronyms found in Table 4.2
†Significantly (p<0.05) different from SB
†† Group x condition interaction (p<0.05)
Values are mean +/- standard deviation
4.1 Heart Rate and Blood Pressure
Table 4.3 shows the SBP, DBP, and HR responses measured during data
collection. There were several main effects of the breathing condition. HR and BP
measures during PB were different from those observed during the SB stage. The main
effect on HR; however, was modified by a group by condition interaction. There was
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only one main effect of group. The HR decreased from the SB stage to PB in the CHF
and increased from SB to PB in the control group.
4.2 CHF vs. Control: Fast Fourier Transform
Table 4.4 shows the mean scores for HRV components following analysis using
the FFT method. There was only one significant difference between the CHF and control
group using FFT. This difference was a main effect of group on the R-R intervals. The
R-R intervals were greater in the control as compared to CHF group. The R-R intervals
during both the SB and PB (p=0.001, p=0.022, respectively) were different between
groups.
4.3 CHF vs. Control: Discrete-Wavelet Transform
The values for the derived wavelet LF/HF ratio are listed in Table 4.4. There was
a group by condition interaction on the wavelet LF/HF ratio (p=0.024) between groups in
the SB stage. This was such that the LF/HF ratio was higher in the control group as
compared to the CHF group.
4.4 Breathing Condition Effects
A mixed model ANOVA and then paired t-tests were used to examine differences
between breathing conditions within both the CHF and control group. Table 4.3 shows
the values (†) in which there were several significant differences between the SB and PB
stages. The values shown were obtained as a result of the FFT method. The SDNN
values were higher during PB as compared to the SB stage. There was a difference found
between the two stages (p<0.05), but there were no interactions between the control and
CHF group. The R-R intervals were different (p<0.01) between the PB and the SB stage
being that they were lower during the PB stage. As mentioned in the previous section,
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there was also a difference between groups in the R-R intervals. The R-R intervals were
higher in the control group. The LFnu values significantly lower in the PB (p<0.01) as
compared to the SB stage. Although the values for the control group were higher than
that of the CHF group, the LFnu values between the groups were not significantly
different. The HFnu values were significantly different between the SB and PB
conditions. This was such that the HFnu values were greater (p<0.01) during the PB
stage. There were no differences detected in HFnu values between the groups. Overall,
the values for the pNN50 parameter were smaller in the CHF group than that of the
control group. However, there were no significant differences between the groups. The
differences were detected during the breathing stages. The pNN50 values during PB
were lower during the SB stage, and there was a significant difference (p<0.01) between
the two breathing conditions. The CHF group showed greater values in RMSSD than
that of the control group, but the values were not found to be significantly different. The
RMSSD values were different (p<0.01) between the two stages. The RMSSD was higher
during the PB stage than it was during SB. Lastly, the LF/HF ratio was significantly
different between the PB and SB stages. The LF/HF ratio in the PB was found to be
smaller than that of the SB stage (p<0.01). The wavelet technique detected no
differences between the SB and PB conditions in the derived LF/HF ratio.
4.5 Wavelet Powers for CHF and Control Groups
In Figures 4.1 and 4.2 each wavelet power level is plotted for participants of both
groups. The power levels on the x-axis reflect frequency (HF and LF). As the power
levels increase, the frequency level decreases. In this study, the levels 3 and 4 roughly
represent the parasympathetic (HF) activity while levels 5 and 6 represent the
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Table 4.4-Wavelet and FFT Values

CHF
Breathing
Condition

SB

Control
PB

SB

PB

SDNN

51.2±47

61±38.4†

52.5±11.4

59.4±19.4†

R-R

755±81.3

745±95.5† 1002±98*

926±134*†

LFnu

46.9±25

31±15†

62.1±21.2

43±29.8†

HFnu

53.3±25

69±15.3†

37.9±21.3

56.8±29.7†

LF/HF

1.6±1.9

.503±.40†

2.42±1.9

1.67±2.1†

pNN50

15.3±23.2

17.8±22.4† 25±21

23.1±22.5†

RMSSD

57.2±73.4

71.1±59.7† 45.3±28

45.9±28.6†

Wavelet
ratio

3.39±.75

3.44±.942

4.04±.86*

4.41±.43*

Acronyms are defined in Table 4.2
* Different from CHF (p<0.05)
† Different from SB condition (p<0.05)
Values are mean +/- standard deviation

area of sympathetic (LF) activity. The y-axis represents coefficients or the standard
deviation for the wavelet powers. Figure 4.1 shows the wavelets for the data collected
during the SB portion of testing and Figure 4.2 shows the data collected during PB.
4.6 FFT Values for LF in Normalized Units
Figure 4.3 shows the LFnu values obtained via the FFT. The sympathetic activity
represented by LFnu is plotted for both the CHF and control groups. The LFnu is the
absolute LF power measured in normalized units. The LF normalized units (LFnu)
represents the relative value of the LF power component in proportion to the total power
(Malliani, Pagani, Lombardi, & Cerutti, 1991). These values were plotted in order to
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visualize a “region of overlap” that occurred following the FFT analysis. It is important
here to note that only LF powers were focused on because this is where separation was
seen using the wavelet technique. Since we are comparing the two methods, we looked
at the ability of the FFT to do what the wavelet has done in terms of separating the CHF
and control groups.

LFnu Values via FFT
90
80
70
60
Region 50
Of
Overlap 40

LFnuSB
LFnuPB

30
20
10
0

CHF

Control

Figure 4.3-LFnu Values via FFT
4.7 Six-Minute Walk and BMI
The means for BMI and six minute walk distances for the CHF and control are
listed in Table 4.5. The group means were figured for both the CHF and control groups
as a whole. It is important to note that the BMI and walk distances were examined for
correlations with the derived wavelet ratios during SB and PB. Also note that the sample
size (N) is different than the sample size listed in Table 4.1. There was no correlation
found between BMI and wavelet derived ratios during SB or PB. However, there was a
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positive correlation (Pearson r=0.648) between the group mean walk distance and
wavelet ratios during SB. The correlation was found to be significant (p<0.01). There
was no such correlation between the walk distances and wavelet ratios during the PB
stage (p=0.08).

Table 4.5-Six-Minute Walk and BMI
All Participants
13

N
6 Min Walk Distance (m)*
BMI ( kg/m2 )*

354.7 +\- 194.8
31.3 +\- 11.1

*Values are mean +\- standard deviation
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CHAPTER 5—DISCUSSION
The primary purpose of this investigation was to examine the extent to which
FFT, a common type of spectral analysis, and the newly introduced discrete wavelet
transformation (DWT) could discriminate between a group of CHF patients and agematched controls. Due to the potential for the test condition to exert considerable
influence on HRV, data were collected under spontaneous and paced breathing conditions
(SB and PB, respectively). The heart rates and blood pressures of the participants were
also examined during data collection.
In general, the observed results appear to be as expected. Our results were similar
to those of Ashkenazy et al. (1998). In reference to HRV profiles, the wavelet showed
(Figure 4.1 and 4.2) almost complete separation between the control group and the CHF
group. The results were similar to Ashkenazy et al. in the fact that any separation was
seen. However, our results differed from the Ashkenazy et al. study because the
separation was only seen during the sympathetic activity (L5-L6) region. Although it
was more distinct in the SB stage, there was separation seen in both the PB and SB
conditions. The values for the control group were higher overall in the parasympathetic
(L3-L4) and sympathetic regions. The values also increased in greater magnitudes from
level 1 to level 7 in the control group, revealing a greater overall LF and HF variation in
the control group. By the wavelet data, one could conclude that the control participants
had greater parasympathetic- and sympathetic-mediated HRV. The main finding is that
DWT analysis appeared to have a greater ability to discriminate between the control and
CHF group.
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5.1 Heart Rate and Blood Pressure
In this study we also examined HR and blood pressures of the participants in each
group. These variables were examined to provide further insight into how the two groups
differed during data collection. As expected, the mean blood pressures and resting heart
rates were higher in the CHF group. Still, there were no significant differences in SBP or
DBP according to group. This may be explained by the fact that CHF individuals were
taking medication to control high blood pressure. In addition, high blood pressures (<
140/90 mmHg) were recorded for two of the control participants.
The HR, SBP, and DBP during SB were significantly different from those during
PB. However, the influence of breathing on the HR was different between the CHF and
control group. In the CHF group, HR decreased from the SB to PB stage. Then, in the
control group the HR increased from SB to PB. Thus, it seems guided breathing caused
the heart to beat slightly faster in the control group while it slowed the heart in the CHF
group. These results also suggest that there was no difference in the way the two groups
responded to influence of breathing on the SBP or DBP. Thus, HR seemed to respond
differently between the groups as a result of breathing while blood pressures in both
groups had similar responses to the breathing conditions.
5.2 FFT Analysis
The LFnu values for both groups obtained by FFT method were also plotted in
part because LF (sympathetic) has a tendency to be more pronounced in CHF patients
even at rest (Task Force, 1996). There was no distinct separation shown between the two
groups. Thus, it is indicated that the FFT lacks the ability that the wavelet had to
discriminate between the CHF and control group. Figure 4.3 visually illustrates the
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inability of the FFT to discriminate between the CHF and control group. These data are
consistent with the findings of Berbari and Lazzara (1992), Breithardt et al. (1982), and
Zimmerman, Adamec, Simonin, and Richez (1985). These investigators have shown
overlap to suggest that the FFT is inefficient in detecting lower frequencies. The lower
frequencies are typically where most late potentials or disturbances in ECG rhythms are
found. Late potentials have been shown to be predictive of rhythm disturbances such as
sustained ventricular tachycardia (Zimmerman et al., 1985). Thus, the inability to detect
them can lead to misdiagnoses and be detrimental in a clinical setting.
The R-R interval is the time duration between each consecutive R wave in an
ECG. HRV is the term used to describe variations of these R-R intervals. The data
shows the control group to display greater overall variability in R-R intervals than the
CHF group. Here, the difference between groups was detected by the FFT. This
information is consistent with the findings of Stein and Kleiger (1999), who reasoned that
an increased HRV reflects increased autonomic modulation of the heart. Increased
autonomic modulation in comparison to a diminished autonomic modulation of the heart
usually exists in an individual without cardiovascular disease.
The effects of the breathing conditions on the two groups were also examined in
this study. The FFT method was able to detect differences between the SB and PB
conditions. The differences were detected in all of the HRV parameters (LF, HF, SDNN,
R-R, etc.). This indicates that the HRV analyzed by FFT is affected by breathing
patterns, while the HRV analyzed by the wavelet technique is not. However, the ability
of the FFT to recognize breathing pattern differences may pose as an advantage in some
cases. In studies where breathing patterns are the primary concern or various breathing
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patterns are being examined, FFT may be a more powerful tool than the wavelet. Such
studies may include those examining the cause of sleep apnea. It is also possible that
breathing patterns interfere with accuracy of the HRV analysis if the method of HRV
analysis is affected by it. In this case, the wavelet technique may prove a more reliable
choice of analysis.
The ability of the FFT to detect breathing differences without showing any
separation between the groups may be a result of underlying physiological phenomenon
as well as a function of the limitations imposed by the assumption of the FFT.
5.3 Wavelet Analysis
The index of sympathovagal balance (LF/HF) was examined by both the FFT and
wavelet techniques. The LF/HF ratio is considered a measure of sympathovagal or
autonomic balance and reflects sympathetic modulations. Both techniques showed the
control group to have higher LF/HF values than the CHF group. However, only the
wavelet detected a significant difference (p=0.024) in the LF/HF ratio between the CHF
and control group. This difference was detected during the SB stage. Figures 4.1 and 4.2
illustrate the separation that the wavelet detected between the CHF and control group.
The illustrations allow one to visualize the greater separation between the groups seen in
the SB condition (Figure 4.1).
The higher values in the control group are similar to the findings of Ashkenazy et
al. (1998). However, our results differed from Ashkenazy et al. because the separation
between groups became more evident in the LF power, meaning only the LF values were
higher in the control group. Whereas, the data from Ashkenazy et al. showed higher
values and thus separation between groups in both HF and LF powers. The DWT used
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by Ashkenazy et al. was the Daubechies 10-tap model. For this investigation, the
Daubechies 4-tap DWT was employed. It was concluded by Ashkenazy et al. (1998) that
in order to obtain a complete separation between healthy subjects and patients a range of
scales, instead of just one, has to be considered. Perhaps, the Daubechies 10-tap filter is
closer to the ideal frequency response than the 4-tap. This may also explain the more
distinct separation seen by Ashkenazy et al. Equally likely, however, is the possibility
that the clinical status of the control group may have involved “silent” disease or other
confounding factors such as variation in the fitness levels of the participants.
Regardless, the 4-tap DWT employed here, demonstrated greater discriminatory
ability than the FFT in this particular study. This may be explained by the tendency of
the FFT analysis to make certain assumptions about ECG data that the wavelet does not.
The FFT assumes that the ECG data are stationary signals and that the ECG signal is a
continuous time series. The FFT can only accurately describe an event in either the
frequency or time domain. Unlike the wavelet, it cannot describe an event in both the
time and frequency domain simultaneously. The ability of the wavelet to do this allows a
multi-resolution analysis of data with different behavior on different scales. This dual
localization renders functions with intrinsic inaccuracies into reliable data when they are
transformed into the wavelet domain (Ashkenazy et al., 1998). Furthermore, spectral
analyses such as FFT often include transients caused by artifacts, ectopic beats, and
noise. All of which possess the potential to impact the power spectrum. This can limit
the sensitivity of the FFT technique considerably, and in turn limit its overall
applicability.
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5.4 Limitations
Overall, the limitations of this particular study evolved around some aspect of the
subject population tested. The control group may not have been extremely well matched
to the CHF group. The individuals were not matched based on gender, ethnicity or
geographical location and there were more females than males in this study. All of these
factors have been shown to be influential. In addition, the medications that the CHF
individuals were taking may have impacted the results. Thus, it should be stated that the
external validity of this study might have been limited in accordance to these factors.
Based on the positive correlation between derived wavelet ratios and the walk
distances (Figure 5.1), it is possible that the participant cardiovascular fitness levels
influenced the data. This poses another limitation to our data in regard to what was being
detected by the wavelet technique. Perhaps this is why there was separation found
between the groups during the SB stage. It is possible that the wavelet was detecting the
separation based on the fitness variable as opposed to disease. It is also possible that
disease is influencing the fitness levels, which in turn are being detected by the wavelet.
However, this is only speculation and should be further investigated to provide more
insight as to what the wavelet is detecting.
5.5 Future Directions
While this study and similar investigations attempt to develop the most effective
tool of HRV analysis possible, other studies should concentrate on examining treatment
strategies. For the Kinesiologist, one primary focus should be on physical activity as a
form of treatment for those who experience autonomic dysfunction. Some studies have
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looked at the effects of physical conditioning on autonomic function. Myslivecek,
Brown, and Wolfe (2002) found vagal modulation was higher and sympathetic
modulation was lower in exercise groups compared to pre-training values. Also, vagal
modulation is increased following moderate intensity aerobic conditioning in middleaged women (Myslivecek et al., 2002). Another study (Perini, Fisher, Veicsteinas, &
Pendergrast, 2002) revealed aerobic exercise training to improve exercise capacity, but
failed to demonstrate changes in autonomic regulation of the heart in elderly (70-80 yrs)
men and women. Another study by Melanson and Freedson (2001) concluded that a
moderate-to-vigorous-intensity exercise program produces increases in time- and
frequency-domain measures of HRV within 12 weeks. With findings of this nature, it is
important to further investigate physical activity and its effects on autonomic regulation
in aims to discover overall effective treatment strategies for dysautonomia.
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In addition, there is a need for studies to develop normative data relating wavelet
scoring of HRV to cardiovascular risk. Whether the risk of cardiovascular disease varies
depending on race, gender, body composition, or geographical location has not yet been
established. Also, investigations should report construct validity of the DWT of HRV
during exercise, tilt, and mental stress.
5.6 Summary and Conclusions
The purpose of this investigation was inspired by the desire to determine the most
efficient method for analyzing HRV. The HRV analysis is an accepted and common
method by which the ANS is monitored. It has been established by previous studies that
ANS monitoring is of importance for the purpose of enhancing risk stratification and
treatment for cardiac diseased populations.
The results support our hypothesis that the wavelet technique would be a more
powerful tool for discriminating between the cardiac diseased and control group
participants. The data suggested that the control participants had greater overall
variability and the magnitude of LF and HF variation was greatest in this group as well.
Also, the wavelet seemed to be unaffected by breathing patterns. However, the FFT was
able to detect differences in groups as a result of breathing pattern. It is apparent that
both the FFT and wavelet provide unique information about autonomic modulation of the
heart. Therefore, further research should aim to develop the most effective tools for HRV
analysis. HRV studies should also enhance the understanding of physiological
phenomena, actions of medications, and disease mechanisms (Task Force, 1996).
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